|
US4210478A
(en)
*
|
1973-05-08 |
1980-07-01 |
International Paper Company |
Method of making a catheter
|
|
US3959429A
(en)
*
|
1975-02-03 |
1976-05-25 |
International Paper Company |
Method of making a retention catheter and molding a tip thereon
|
|
US3985601A
(en)
*
|
1975-05-05 |
1976-10-12 |
Quantum, Inc. |
Method for producing a balloon type catheter having a smooth continuous outer surface
|
|
US4361152A
(en)
*
|
1975-05-27 |
1982-11-30 |
The Kendall Company |
Catheter
|
|
US4188954A
(en)
*
|
1976-08-05 |
1980-02-19 |
The Kendall Company |
Catheter with improved balloon assembly
|
|
US4055187A
(en)
*
|
1976-08-05 |
1977-10-25 |
The Kendall Company |
Catheter with improved balloon assembly
|
|
US4082114A
(en)
*
|
1977-01-28 |
1978-04-04 |
The Trane Company |
Valve assembly for use in an air distribution system
|
|
FR2386406A1
(fr)
*
|
1977-04-08 |
1978-11-03 |
Technological Supply |
Procede pour la fabrication d'un catheter a ballonnet
|
|
US4168710A
(en)
*
|
1977-08-10 |
1979-09-25 |
The Kendall Company |
Balloon cuff and catheter assembly
|
|
US4143651A
(en)
*
|
1977-11-03 |
1979-03-13 |
The Kendall Company |
Catheter
|
|
US4222384A
(en)
*
|
1977-11-09 |
1980-09-16 |
Biomedical Engineering Associates, Inc. |
Catheter
|
|
JPS552348U
(es)
*
|
1978-06-21 |
1980-01-09 |
|
|
|
US4284459A
(en)
*
|
1978-07-03 |
1981-08-18 |
The Kendall Company |
Method for making a molded catheter
|
|
DE2837813C3
(de)
*
|
1978-08-30 |
1981-08-20 |
Willy Rüsch GmbH & Co KG, 7053 Kernen |
Verfahren zum Herstellen eines medizinischen Tubus oder Katheters
|
|
US4251305A
(en)
*
|
1978-11-01 |
1981-02-17 |
Baxter Travenol Laboratories, Inc. |
Method of radiant heat sealing of a balloon onto a catheter employing tinted shrink tubing
|
|
JPS56152655A
(en)
*
|
1980-04-28 |
1981-11-26 |
Terumo Corp |
Balloon catheter with backward flow preventing valve
|
|
US4447228A
(en)
*
|
1980-05-05 |
1984-05-08 |
The Kendall Company |
Catheter
|
|
US4445890A
(en)
*
|
1980-05-05 |
1984-05-01 |
The Kendall Company |
Catheter
|
|
US4445891A
(en)
*
|
1980-05-05 |
1984-05-01 |
The Kendall Company |
Catheter
|
|
FR2513566A1
(fr)
*
|
1981-09-29 |
1983-04-01 |
Matburn Holdings Ltd |
Procede pour fixer ensemble les matieres plastiques et le caoutchouc
|
|
FR2521014B1
(fr)
*
|
1982-02-05 |
1988-06-03 |
Matburn Holdings Ltd |
Instrument chirurgical tubulaire, notamment catheter de thrombectomie
|
|
DE3438131C2
(de)
*
|
1984-10-18 |
1986-08-21 |
Werner Dr.med. 4330 Mülheim Schubert |
Vorrichtung zur Beseitigung von Konkrementen
|
|
US4787892A
(en)
*
|
1984-12-18 |
1988-11-29 |
The Kendall Company |
Nephrostomy catheter with formed tip
|
|
US4636272A
(en)
*
|
1985-02-19 |
1987-01-13 |
Cordis Corporation |
Process for thermally bonding plastic tubes
|
|
US4782834A
(en)
*
|
1987-01-06 |
1988-11-08 |
Advanced Cardiovascular Systems, Inc. |
Dual lumen dilatation catheter and method of manufacturing the same
|
|
US4861337A
(en)
*
|
1988-03-02 |
1989-08-29 |
Sherwood Medical Company |
Collapsible urethral catheter
|
|
US5095915A
(en)
*
|
1990-03-19 |
1992-03-17 |
Target Therapeutics |
Guidewire with flexible distal tip
|
|
JP2502174B2
(ja)
*
|
1990-08-07 |
1996-05-29 |
富士システムズ株式会社 |
バル―ンカテ―テルの製造方法
|
|
US5257451A
(en)
*
|
1991-11-08 |
1993-11-02 |
Ep Technologies, Inc. |
Method of making durable sleeve for enclosing a bendable electrode tip assembly
|
|
US5460608A
(en)
*
|
1994-01-25 |
1995-10-24 |
Scimed Life Systems, Inc. |
Kink free catheter
|
|
US5527281A
(en)
*
|
1995-07-27 |
1996-06-18 |
Haas; Joseph A. |
Substitute tip for urethral catheter
|
|
SE9600276D0
(sv)
|
1996-01-25 |
1996-01-25 |
Astra Ab |
A wetting device for wetting a hydrophilic catheter and a urine collection bag incorporating said device
|
|
US5965532A
(en)
*
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
|
ES2239801T3
(es)
|
1997-04-02 |
2005-10-01 |
The Brigham And Women's Hospital, Inc. |
Uso de un agente para disminuir el riesgo de enfermedad cardiovascular.
|
|
DK1096952T3
(da)
|
1998-07-15 |
2008-08-25 |
Brigham & Womens Hospital |
Polysaccharidvaccine mod stafylokok-infektioner
|
|
US6368301B1
(en)
*
|
1999-12-21 |
2002-04-09 |
Advanced Cardiovascular Systems, Inc. |
Catheter having a soft distal tip
|
|
WO2001066772A2
(en)
|
2000-03-08 |
2001-09-13 |
Massachusetts Institute Of Technology |
Heparinase iii and uses thereof
|
|
US20030060487A1
(en)
*
|
2000-04-12 |
2003-03-27 |
Bamdad R. Shoshana |
Treatment of neurodegenerative disease
|
|
KR100434720B1
(ko)
*
|
2001-01-03 |
2004-06-07 |
이근호 |
발룬 카테테르의 제조방법
|
|
US6692461B2
(en)
|
2001-08-07 |
2004-02-17 |
Advanced Cardiovascular Systems, Inc. |
Catheter tip
|
|
US6918920B1
(en)
*
|
2001-11-01 |
2005-07-19 |
Advanced Cardiovascular Systems, Inc. |
Catheter having an improved distal tip
|
|
JP4828795B2
(ja)
*
|
2002-03-11 |
2011-11-30 |
モメンタ ファーマシューティカルズ インコーポレイテッド |
硫酸化多糖類の分析
|
|
EP1483283A4
(en)
|
2002-03-13 |
2007-04-11 |
Signum Biosciences Inc |
MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
|
|
US7344505B2
(en)
*
|
2002-10-15 |
2008-03-18 |
Transoma Medical, Inc. |
Barriers and methods for pressure measurement catheters
|
|
PL1897548T5
(pl)
|
2003-02-28 |
2025-03-17 |
The Johns Hopkins University |
Regulacja komórek T
|
|
AU2004248187A1
(en)
|
2003-06-12 |
2004-12-23 |
University Of Colorado System Technology |
Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
|
|
JP2007502991A
(ja)
|
2003-08-20 |
2007-02-15 |
バイオサイト インコーポレイテッド |
生物活性ナトリウム利尿ペプチドを測定するための、およびその治療可能性を向上させるための方法および組成物
|
|
US7655000B2
(en)
|
2003-09-26 |
2010-02-02 |
Tyco Healthcare Group Lp |
Urology catheter
|
|
US7972350B2
(en)
*
|
2004-01-29 |
2011-07-05 |
Boston Scientific Scimed, Inc. |
Catheter tip
|
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
|
CN101106997A
(zh)
|
2004-08-17 |
2008-01-16 |
约翰·霍普金斯大学 |
Pde5抑制剂组合物及治疗心脏病征候的方法
|
|
EP2338994B1
(en)
|
2004-09-02 |
2014-03-19 |
Yale University |
Regulation of oncogenes by microRNAs
|
|
WO2006034454A1
(en)
*
|
2004-09-23 |
2006-03-30 |
The Trustees Of The University Of Princeton |
Bcl-2 family member and bh-3 only proteins for use in development of peptidomimetics
|
|
EP2927693A1
(en)
|
2004-10-06 |
2015-10-07 |
The Brigham and Women's Hospital |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
|
WO2006052940A2
(en)
*
|
2004-11-05 |
2006-05-18 |
Asthmatx, Inc. |
Medical device with procedure improvement features
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
CA2601777A1
(en)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
EP1858542A4
(en)
*
|
2005-02-24 |
2009-08-19 |
Joslin Diabetes Center Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF VASPEREPERMABILITY
|
|
MX2007010371A
(es)
*
|
2005-02-25 |
2008-01-11 |
Tetralogic Pharmaceuticals |
Inhibidores dimericos iap.
|
|
WO2007002528A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Yale University |
Anti-aging micrornas
|
|
AU2006270066A1
(en)
|
2005-07-19 |
2007-01-25 |
University Of Tennessee Research Foundation |
LPA2 receptor agonist inhibitors of CFTR
|
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
CA2617642A1
(en)
*
|
2005-08-09 |
2007-02-22 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
US20080021198A1
(en)
*
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
|
EP1963364A2
(en)
*
|
2005-12-01 |
2008-09-03 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Compounds and methods for inhibiting apoptosis
|
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
MX2009000824A
(es)
*
|
2006-07-24 |
2009-02-04 |
Tetralogic Pharmaceuticals Cor |
Antagonistas dimericos de las proteinas inhibidoras de la apoptosis.
|
|
WO2008014240A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
JP5452223B2
(ja)
*
|
2006-07-24 |
2014-03-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ阻害剤
|
|
US20100143499A1
(en)
*
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20080153773A1
(en)
*
|
2006-08-08 |
2008-06-26 |
Yigong Shi |
Modulators of phosphotyrosyl phosphatase activator
|
|
WO2008060791A2
(en)
*
|
2006-10-13 |
2008-05-22 |
The Trustees Of The University Of Princeton |
Modulators of protein phosphatase 2a
|
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
|
CA2674493C
(en)
|
2007-01-05 |
2017-05-09 |
Massachusetts Institute Of Technology |
Compositions of and methods of using sulfatases from flavobacterium heparinum
|
|
WO2008086529A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
WO2008109773A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cornell Research Foundation, Inc. |
Chronic obstructive pulmonary disease susceptibility and related compositions and methods
|
|
US20100111943A1
(en)
*
|
2007-03-22 |
2010-05-06 |
Medical College Of Georgia Research Institute, Inc |
Compositions and methods for inhibiting cancer metastasis
|
|
WO2008122039A2
(en)
*
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
US9139876B1
(en)
|
2007-05-03 |
2015-09-22 |
Momenta Pharmacueticals, Inc. |
Method of analyzing a preparation of a low molecular weight heparin
|
|
ES2537349T3
(es)
|
2007-06-08 |
2015-06-05 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para determinar un subtipo de carcinoma hepatocelular
|
|
US20090274682A1
(en)
*
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
|
US20090233858A1
(en)
*
|
2008-02-26 |
2009-09-17 |
The Trustees Of Princeton University |
Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation
|
|
US20090280167A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
|
US20100146875A1
(en)
*
|
2008-05-30 |
2010-06-17 |
John Redding |
Support post structure
|
|
WO2010017103A2
(en)
*
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
|
WO2010033531A1
(en)
|
2008-09-17 |
2010-03-25 |
Tetralogic Pharmaceuticals Corp. |
Iap inhibitors
|
|
US8729053B2
(en)
*
|
2008-09-22 |
2014-05-20 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Nuclear factor kappa B pathway inhibitor composition and use of same
|
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
|
CA2759733C
(en)
|
2009-04-23 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ror1 antibodies
|
|
ES2675236T3
(es)
|
2009-04-30 |
2018-07-09 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Schweinfurthinas y usos de las mismas
|
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
IN2012DN00352A
(es)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
|
EP2456787A4
(en)
|
2009-07-24 |
2013-01-30 |
Univ Leland Stanford Junior |
CYTOKIN COMPOSITIONS AND METHOD FOR THEIR USE
|
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
|
CA2776143A1
(en)
|
2009-10-01 |
2011-04-07 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
WO2011090948A1
(en)
*
|
2010-01-19 |
2011-07-28 |
Momenta Pharmaceuticals, Inc. |
Evaluating heparin preparations
|
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
|
US20110262406A1
(en)
|
2010-04-21 |
2011-10-27 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
WO2012012627A1
(en)
|
2010-07-22 |
2012-01-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of preventing or treating viral infection
|
|
ES2657970T3
(es)
|
2010-12-01 |
2018-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticuerpos contra ROR1 de conejo/ser humano quiméricos
|
|
SG10201600836PA
(en)
|
2011-02-03 |
2016-03-30 |
Mirna Therapeutics Inc |
Synthetic mimics of mir-34
|
|
JP2014506789A
(ja)
|
2011-02-03 |
2014-03-20 |
マーナ セラピューティクス インコーポレイテッド |
ｍｉＲ−１２４の合成模倣体
|
|
WO2012115952A1
(en)
|
2011-02-21 |
2012-08-30 |
Momenta Pharmaceuticals, Inc. |
Evaluating heparin preparations
|
|
US9296818B2
(en)
|
2011-03-14 |
2016-03-29 |
Marene Inga-Britt Landstrom |
Cleavage inhibitors of transforming growth factor beta type I receptor and uses thereof in cancer therapy
|
|
CA2832540C
(en)
|
2011-04-08 |
2020-09-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
|
|
BR112013027057A2
(pt)
|
2011-04-21 |
2020-08-11 |
Trustees Of Tufts College |
composições e métodos para a estabilização de agentes ativos
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
AU2012284097B2
(en)
|
2011-07-18 |
2017-08-03 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
WO2013020044A1
(en)
|
2011-08-03 |
2013-02-07 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Treatment of fibrosis using microrna-19b
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
ES2654060T3
(es)
|
2011-10-20 |
2018-02-12 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Receptores de antígenos quiméricos anti-CD22
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP2828290B1
(en)
|
2012-03-23 |
2018-08-15 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
WO2013162828A1
(en)
|
2012-04-27 |
2013-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Use of cpg oligonucleotides co-formulated with an antibiotic to accelarate wound healing
|
|
WO2013169691A1
(en)
|
2012-05-07 |
2013-11-14 |
Trustees Of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
|
US9119858B2
(en)
|
2012-08-21 |
2015-09-01 |
Genesys Research Institute, Inc. |
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
|
|
RU2658485C2
(ru)
|
2012-10-24 |
2018-06-21 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы м971
|
|
EP2931272A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
|
WO2014093726A1
(en)
|
2012-12-12 |
2014-06-19 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
|
JP6457999B2
(ja)
|
2013-03-14 |
2019-01-23 |
ザ チルドレンズ メディカル センター コーポレーション |
処置に関してがんの対象を識別するためのｃｄ３６の使用
|
|
AU2014233480B2
(en)
|
2013-03-15 |
2018-08-09 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
|
US20160052985A1
(en)
|
2013-04-04 |
2016-02-25 |
Ieo - Istituto Europeo Di Oncologia Srl |
Thymic stromal lymphopoietin fragments and uses thereof
|
|
EP2994758B1
(en)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarkers for age-related macular degeneration (amd)
|
|
KR20160030099A
(ko)
|
2013-06-25 |
2016-03-16 |
더 월터 앤드 엘리자 홀 인스티튜트 오브 메디컬 리서치 |
세포내 감염의 치료 방법
|
|
WO2015006543A1
(en)
|
2013-07-10 |
2015-01-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for predicting and detecting tumor metastasis in kidney cancer
|
|
AU2014340241B2
(en)
|
2013-10-21 |
2018-11-01 |
Salk Institute For Biological Studies |
Mutated fibroblast growth factor (FGF) 1 and methods of use
|
|
CA2932424C
(en)
|
2013-12-06 |
2023-10-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same
|
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
|
AU2015235978B2
(en)
|
2014-03-26 |
2019-08-08 |
Children's Medical Center Corporation |
Cyclic prosaposin peptides and uses thereof
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
ES2966886T3
(es)
|
2014-05-09 |
2024-04-24 |
Univ Yale |
Partículas recubiertas con poliglicerol hiperramificado y métodos de elaboración y uso de las mismas
|
|
EP3193933B1
(en)
|
2014-09-17 |
2021-04-28 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Anti-cd276 antibodies (b7h3)
|
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
CN115925878A
(zh)
|
2015-06-05 |
2023-04-07 |
艾比欧公司 |
用于治疗纤维化的内皮抑素片段和变体
|
|
EP3831844B1
(en)
|
2015-06-26 |
2024-03-13 |
Prindex S.r.l. |
Diagnosis and therapy of multiple sclerosis
|
|
WO2017004142A1
(en)
|
2015-06-29 |
2017-01-05 |
Children's Medical Center Corporation |
Treatment for myopathy
|
|
EP3331549B1
(en)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Improved microbe-binding molecules and uses thereof
|
|
UA125718C2
(uk)
|
2016-01-20 |
2022-05-25 |
Зе Скріппс Ресеарч Інстітьют |
Композиції антитіл до ror1 і пов'язані з ними способи
|
|
SG11201806121PA
(en)
|
2016-01-20 |
2018-08-30 |
Scripps Research Inst |
Ror2 antibody compositions and related methods
|
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
|
US10293005B2
(en)
|
2016-04-19 |
2019-05-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of gram negative species to treat atopic dermatitis
|
|
CN109310626A
(zh)
|
2016-04-19 |
2019-02-05 |
美利坚合众国,由健康及人类服务部部长代表 |
革兰氏阴性种治疗特应性皮炎的用途
|
|
EP4092045A1
(en)
|
2016-05-16 |
2022-11-23 |
Checkmab S.R.L. |
Markers selectively deregulated in tumor-infiltrating regulatory t cells
|
|
CA3025516A1
(en)
|
2016-05-27 |
2017-11-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Flt3-specific chimeric antigen receptors and methods using same
|
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
|
US20190201414A1
(en)
|
2016-07-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Inhibitor of heme degradation for use to improve antibiotic treatment of mycobacterium tuberculosis infection
|
|
US11260132B2
(en)
|
2017-03-16 |
2022-03-01 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
EP3615937B1
(en)
|
2017-04-25 |
2026-01-28 |
Prothera Biologics, Inc. |
Methods for quantifying inter-alpha inhibitor proteins
|
|
US11447546B2
(en)
|
2017-07-20 |
2022-09-20 |
Nbe-Therapeutics Ag |
Human antibodies binding to ROR2
|
|
KR20230008269A
(ko)
|
2017-08-07 |
2023-01-13 |
엔비이-테라퓨틱스 아게 |
생체 내 내성이 높은 항체 약물 결합체
|
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
|
KR20210013080A
(ko)
|
2018-05-11 |
2021-02-03 |
포르테 서브시디어리, 인크. |
피부 병태의 치료를 위한 조성물
|
|
WO2020072805A1
(en)
|
2018-10-04 |
2020-04-09 |
Rutgers, The State University Of New Jersey |
Methods of reducing type 2 cytokine-mediated inflammation using neuromedin peptides
|
|
US11266617B2
(en)
|
2018-10-16 |
2022-03-08 |
Massachusetts Institute Of Technology |
Beta-hydroxybutyrate encapsulated PLGA nanoparticle compositions
|
|
JP7658579B2
(ja)
|
2018-10-19 |
2025-04-08 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
操作された長鎖散在反復エレメント（ｌｉｎｅ）トランスポゾンおよびそれらの使用方法
|
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
|
BR112021013824A2
(pt)
|
2019-01-18 |
2021-12-14 |
Janssen Biotech Inc |
Receptores de antígeno quiméricos gprc5d e células que expressam os mesmos
|
|
KR20210122275A
(ko)
|
2019-01-30 |
2021-10-08 |
얀센 파마슈티카 엔.브이. |
분자 아형에 기초하여 전립선암을 치료하는 방법
|
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
|
WO2020210719A1
(en)
|
2019-04-10 |
2020-10-15 |
Elevatebio Management, Inc. |
Flt3-specific chimeric antigen receptors and methods of using the same
|
|
BR112021023411A2
(pt)
|
2019-05-22 |
2022-02-01 |
Massachusetts Inst Technology |
Composições e métodos de rna circular
|
|
WO2020239478A1
(en)
|
2019-05-28 |
2020-12-03 |
Pharma Mar, S.A. |
Trabectedin for treating sarcomas based on genomic markers
|
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
BR112022001368A2
(pt)
|
2019-07-26 |
2022-05-24 |
Janssen Biotech Inc |
Proteínas que compreendem domínios de ligação ao antígeno de peptidase 2 relacionada à calicreína e seus usos
|
|
AU2020322221A1
(en)
|
2019-07-26 |
2022-03-24 |
Janssen Biotech, Inc. |
Anti-hK2 chimeric antigen receptor (CAR)
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
CN112390894A
(zh)
|
2019-08-12 |
2021-02-23 |
广东东阳光药业有限公司 |
嵌合抗原受体及其应用
|
|
EP4013883A1
(en)
|
2019-08-16 |
2022-06-22 |
Janssen Biotech, Inc. |
Therapeutic immune cells with improved function and methods for making the same
|
|
WO2021099944A1
(en)
|
2019-11-18 |
2021-05-27 |
Janssen Biotech, Inc. |
Anti-cd79 chimeric antigen receptors, car-t cells, and uses thereof
|
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
|
EP3868396A1
(en)
|
2020-02-20 |
2021-08-25 |
Enthera S.R.L. |
Inhibitors and uses thereof
|
|
AU2021225926A1
(en)
|
2020-02-26 |
2022-10-20 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
JP2023517660A
(ja)
|
2020-03-13 |
2023-04-26 |
ヤンセン バイオテツク，インコーポレーテツド |
シグレック３／ｃｄ３３に結合させるための材料及び方法
|
|
WO2021225781A2
(en)
|
2020-05-07 |
2021-11-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
|
WO2021236855A1
(en)
|
2020-05-19 |
2021-11-25 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
JP2023537470A
(ja)
|
2020-08-03 |
2023-09-01 |
ヤンセン バイオテツク，インコーポレーテツド |
ウイルス治療における多方向バイオ輸送のための材料及び方法
|
|
CN112295084B
(zh)
*
|
2020-09-25 |
2023-03-28 |
池州市琼琚信息技术服务有限公司 |
一种热收缩膜固定胶水形状的方法
|
|
WO2022081895A1
(en)
|
2020-10-16 |
2022-04-21 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
EP4059498A1
(en)
|
2021-03-16 |
2022-09-21 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Methods and compositions for treating conditions associated with hypermineralization
|
|
CN117098781A
(zh)
|
2021-03-24 |
2023-11-21 |
詹森生物科技公司 |
靶向cd22和cd79b的抗体
|
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
|
US20240279687A1
(en)
|
2021-06-07 |
2024-08-22 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
WO2022271955A1
(en)
|
2021-06-23 |
2022-12-29 |
Musc Foundation For Research Development |
Novel targeted shrna nanoparticles for cancer therapy
|
|
US12129302B2
(en)
|
2021-08-25 |
2024-10-29 |
Ibio, Inc. |
Anti-CD-25 antibody
|
|
US20250019455A1
(en)
|
2021-09-24 |
2025-01-16 |
Pharmaceutica Nv |
Proteins comprising cd20 binding domains, and uses thereof
|
|
TW202334080A
(zh)
|
2021-11-08 |
2023-09-01 |
美商歐納醫療公司 |
用於遞送環狀聚核苷酸之脂質奈米粒子組合物
|
|
US20250320519A1
(en)
|
2022-05-30 |
2025-10-16 |
Shanghai Circode Biomed Co., Ltd. |
Synthetic circular rna compositions and methods of use thereof
|
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
WO2024094526A1
(en)
|
2022-11-02 |
2024-05-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
6-diazo-5-oxo-l-norleucine prodrugs
|
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
|
AU2023398825A1
(en)
|
2022-12-15 |
2025-06-26 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024205657A2
(en)
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
EP4705481A2
(en)
|
2023-05-05 |
2026-03-11 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024263649A1
(en)
|
2023-06-19 |
2024-12-26 |
Yale University |
Methods and compositions for enrichment and sequencing of expansion-specific rna transcripts
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
AU2024298726A1
(en)
|
2023-07-27 |
2026-02-19 |
Omnilinx Therapeutics Ag |
Endocytic and scavenger receptor-targeting chimeric proteins and uses thereof
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
EP4537907A1
(en)
|
2023-10-10 |
2025-04-16 |
Enthera S.r.l. |
Cd248 inhibitors and uses thereof
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025247961A1
(en)
|
2024-05-31 |
2025-12-04 |
Centre Hospitalier Universitaire Vaudois (C.H.U.V.) |
Lpa-lpar signaling as a therapeutic target or diagnostic tool for brain diseases
|
|
WO2025257176A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257171A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257173A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2026068747A1
(en)
|
2024-09-26 |
2026-04-02 |
Centre Hospitalier Universitaire Vaudois (C.H.U.V.) |
Astrocytic phosphoprotein (pea-15) for use in the treatment and/or prevention of a neuronal disorder
|
|
EP4729541A1
(en)
|
2024-10-16 |
2026-04-22 |
Paolo Fiorina |
Anti- igfbp7 antibodies and uses thereof
|